Rochester Regional Health recently announced that subsidiary ACM Global Laboratories added to its portfolio with the strategic acquisition of Philadelphia-based DrugScan Inc. and DSI Medical Services Inc.
ACM currently operates in more than 65 countries. DrugScan is a best-in-breed toxicology laboratory testing company with 30 years of delivering medication monitoring solutions to health care providers across the U.S.
As toxicology testing demand grows in the wake of the national opioid epidemic, health systems will need to partner with companies like DrugScan to help providers manage and treat patients with complex medication needs.
ACM completed its acquisition of DrugScan and DSI Medical Services in December 2017. ACM will retain the companies’ leadership, locations and brand names. Visit acmgloballab.com for information.